Alpha1-Adrenoreceptor Antagonist
http://www.emea.europa.eu/

Alfa1- adrenoretseptorite antagonist
http://www.emea.europa.eu/

Saquinavir/ ritonavir/ Efavirenz CCR5 antagonist
http://www.emea.europa.eu/

Sakvinaviir/ ritonaviir/ efavirens
http://www.emea.europa.eu/

Leukotriene receptor antagonist ATC-code:
http://www.emea.europa.eu/

Leukotrieeni retseptorite antagonist ATC- kood:
http://www.emea.europa.eu/

It is a leukotriene-1 receptor antagonist.
http://www.emea.europa.eu/

See on leukotrieen- 1 retseptori antagonist.
http://www.emea.europa.eu/

Concurrent Kineret and TNF antagonist treatment
http://www.emea.europa.eu/

Samaaegne ravi Kineret’ i ja TNF- i antagonistiga
http://www.emea.europa.eu/

Concomitant Drug Levels Increased α1-Adrenoreceptor Antagonist
http://www.emea.europa.eu/

Samaaegselt manustatava ravimi plasmakontsentratsiooni suurenemine α1- adrenoretseptorite antagonist
http://www.emea.europa.eu/

Concomitant Drug Levels Increased α 1-Adrenoreceptor Antagonist
http://www.emea.europa.eu/

Samaaegselt manustatava ravimi plasmakontsentratsiooni suurenemine α1- adrenoretseptorite antagonist
http://www.emea.europa.eu/

Laropiprant is a potent and selective antagonist of DP1.
http://www.emea.europa.eu/

Laropiprant on tugevatoimeline ja selektiivne DP1 antagonist.
http://www.emea.europa.eu/

The TNF antagonist therapy was discontinued prior to randomisation.
http://www.emea.europa.eu/

Ravi TNF antagonistiga lõpetati enne randomiseerimist.
http://www.emea.europa.eu/

EMEND is a neurokinin 1 (NK1) receptor antagonist.
http://www.emea.europa.eu/

EMEND on neurokiniin 1 (NK1) retseptorite antagonist.
http://www.emea.europa.eu/

Emend is a neurokinin 1 (NK1) receptor antagonist.
http://www.emea.europa.eu/

Emend on neurokiniin- 1 (NK1) retseptori antagonist.
http://www.emea.europa.eu/

Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code:
http://www.emea.europa.eu/

Farmakoterapeutiline grupp: antihistamiinid – H1 antagonistid, ATC- kood:
http://www.emea.europa.eu/

Fesoterodine is a competitive, specific muscarinic receptor antagonist.
http://www.emea.europa.eu/

Fesoterodiin on konkureeriv spetsiifiline muskariiniretseptori antagonist.
http://www.emea.europa.eu/

SOMAVERT is a potent antagonist of growth hormone action.
http://www.emea.europa.eu/

SOMAVERT on tugev kasvuhormooni antagonist.
http://www.emea.europa.eu/

Naloxone is an antagonist at μ (mu)-opioid receptors.
http://www.emea.europa.eu/

Naloksoon on μ (müü) retseptori antagonist.
http://www.emea.europa.eu/

Risperidone is a selective monoaminergic antagonist with unique properties.
http://www.emea.europa.eu/

Risperidoon on ainulaadsete omadustega selektiivne monoamiinergiline antagonist.
http://www.emea.europa.eu/

17 Pharmacotherapeutic group: angiotensin II antagonist, plain, ATC code:
http://www.emea.europa.eu/

Farmakoterapeutiline grupp: angiotensiin- II antagonist, ATC- kood:
http://www.emea.europa.eu/

Cetrorelix is a luteinising hormone releasing hormone (LHRH) antagonist.
http://www.emea.europa.eu/

Tsetroreliks on luteiniseeriva hormooni vabastajahormooni (LHRH) antagonist.
http://www.emea.europa.eu/

Investigations INR increase (with concomitant vitamin K antagonist therapy).
http://www.emea.europa.eu/

Uuringud INR- i väärtuse suurenemine (samaaegse ravi korral K- vitamiini antagonistidega).
http://www.emea.europa.eu/

Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity.
http://www.emea.europa.eu/

Desloratadiin on mittesedatiivne, pika toimeajaga, perifeerse histamiini H1- retseptori selektiivne antagonist.
http://www.emea.europa.eu/